John Vandermosten
LightNews LightNews
vanjohn10.bsky.social
John Vandermosten
@vanjohn10.bsky.social
31 followers 44 following 540 posts
Life Sciences, Analyst, Media Operations, Investor Awareness
Owner of Unboxing Biotech, a channel that features life sciences executives and their companies.
Posts Replies Media Videos
vanjohn10.bsky.social
Reviva Pharmaceuticals publishes RECOVER vocal biomarker data in Biological Psychiatry
*A Single, Interpretable Vocal Biomarker for Enriching Antipsychotic Clinical Trials
www.biologicalpsychiatryjournal.com/article/S000...
$RVPH
finance.yahoo.com/news/reviva-...
A single, interpretable vocal biomarker for enriching antipsychotic clinical trials
Speech latency, an objective measure of verbal response time, is sensitive to cognitive, social, and motivational factors, and can be measured using recordings of psychiatric interviews. Emerging evid...
www.biologicalpsychiatryjournal.com
January 8, 2026 at 7:48 PM
vanjohn10.bsky.social
CEO Dr Bianco shares TuHURA's work with the #FDA's Oncology Center of Excellence to construct a trial to satisfy requirements for accelerated & full approval of IFx-2.0 in Merkel Cell Carcinoma
$HURA
#TuhuraBio #Bioscience #LifeSciences #Oncology #TargetedTherapies
youtube.com/shorts/eeS09...
IFx 2.0 Trial Design
YouTube video by Unboxing Biotech
youtube.com
January 8, 2026 at 7:27 PM
vanjohn10.bsky.social
The Delta Opioid Receptor & Nobel Prize Discovery:
TuHURA Biosciences CEO Dr James Bianco joins us to talk about work $HURA has done to better understand the delta opioid receptor. Findings tie into the 2025 #NobelPrize in medicine that made discoveries in peripheral immune tolerance. #oncology
January 7, 2026 at 9:31 PM
vanjohn10.bsky.social
Azitra's COO Travis Whitfill to present at Biotech Showcase next week.
*13Jan26
*Hilton SFO Union Square
$AZTR
finance.yahoo.com/news/azitra-...
Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference
Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it will present at ...
finance.yahoo.com
January 7, 2026 at 1:35 PM
vanjohn10.bsky.social
Protalix CEO Dror Bashan pens letter to stockholders emphasizing:
*Development
~Ph2 PRX115
~Renal pipeline-PRX119
~Secarna OligoCreator
*Chiesi, Elfabrio & CHMP flexible dosing
*Dec'25 BioMarin/Amicus Galafold acq
*Elelyso
$PLX
ir.protalix.com/news-release...
Protalix BioTherapeutics Letter to Stockholders | Protalix BioTherapeutics
ir.protalix.com
January 5, 2026 at 2:20 PM
vanjohn10.bsky.social
@lantheus.bsky.social closes SPECT business sale to SHINE Technologies
*Includes Technelite, Neurolite, Xenon Gas & Cardiolite
$LNTH
finance.yahoo.com/news/lantheu...
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians ...
finance.yahoo.com
January 2, 2026 at 2:13 PM
vanjohn10.bsky.social
More Ph1b data from Lexaria for GLP-1 agonist study:
*Rough parity reported between the arms for glucose, cholestrol & LDLs.
*DHT-CBD showed reduced blood pressure
This + other data suggest the best route forward to be DHT-Rybelsus vs DHT-semaglutide.
$LEXX
lexariabioscience.com/2025/12/30/l...
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4 - Lexaria Bioscience
KELOWNA, BC / ACCESS Newswire / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, provides the follo...
lexariabioscience.com
December 31, 2025 at 2:35 PM
vanjohn10.bsky.social
We initiated on Cardiff Oncology with an $8.50 price target.
youtu.be/_pV9tsv2h8Y
See our report at the link below:
s27.q4cdn.com/906368049/fi...
#CardiffOncology #CRDF #Biotech #Oncology
Zacks Initiation on Cardiff Oncology (CRDF)
YouTube video by Unboxing Biotech
youtu.be
December 24, 2025 at 4:47 PM
vanjohn10.bsky.social
#ICYMI, here is the 2nd installment of a conversation with Trinity Capital's Rob Lake who explores post-COVID performance in the life sciences, acknowledges the patent cliff & reviews M&A trends.
$TRIN
youtu.be/be1JI6m7AsU
Conversation with Trinity Capital's Life Science Lead Rob Lake #2
YouTube video by Unboxing Biotech
youtu.be
December 22, 2025 at 4:47 PM
vanjohn10.bsky.social
#ICYMI, we speak with Trinity Capital's Life Science Lead Rob Lake in part 1 of a two part series. We look at some of the ways private capital can be used to help developing companies achieve milestones and limit dilution.
$TRIN
www.youtube.com/watch?v=Dx0E...
Conversation with Trinity Capitals Life Science Lead Rob Lake #1
YouTube video by Unboxing Biotech
www.youtube.com
December 19, 2025 at 2:45 PM
vanjohn10.bsky.social
Athira Pharma to acquire lasofoxifene in Ph3 development with funding participation by Ligand Pharma. $LGND has an agreement to receive milestones & tiered royalty of 6-10% on future next sales.
Drug treats ESR1-mutant breast cancer.
$ATHA
investors.athira.com/news-release...
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million | Athira Pharma
Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations Financing C...
investors.athira.com
December 18, 2025 at 10:45 PM
vanjohn10.bsky.social
Ligand Partner Palvella Therapeutics granted FDA Fast Track designation for QTORIN Rapamycin.
$LGND $PVLA
ir.palvellatx.com/news-release...
Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas - Tue, 12/16/2025 - 07:30
Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need With Fast Track designation, QTORIN™ rapamycin for a...
ir.palvellatx.com
December 17, 2025 at 11:16 PM
vanjohn10.bsky.social
A patient's degree of schizophrenia is often measured by the Positive and Negative Syndrome Scale (PANSS).
Reviva CEO Dr Bhat provides symptom examples.
#schizophrenia #biopharma #biotech
$RVPH
youtu.be/3zYbRsr4xZo
Positive and Negative Symptoms
YouTube video by Unboxing Biotech
youtu.be
December 17, 2025 at 4:38 PM
vanjohn10.bsky.social
Dyadic & Fermbox expand collaboration
*Animal-free proteins & enzymes in multiple markets
*Allows for new $DYAI & Fermbox products to be manufactured & commercialized
*Life sciences, food, nutrition & bioindustrial markets
finance.yahoo.com/news/dyadic-...
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
JUPITER, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineer...
finance.yahoo.com
December 17, 2025 at 4:06 PM
vanjohn10.bsky.social
Protalix Bio & Secarna Pharma enter into collaboration & option agreement
*Novel antisense oligonucleotide therapies
*$PLX will identify targets in renal indications
*Secarna will contribute the OligoCreator AI platform
finance.yahoo.com/news/protali...
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases wi...
finance.yahoo.com
December 17, 2025 at 3:55 PM
vanjohn10.bsky.social
GeoVax #CEO David Dodd provides his perspective on new approaches to #vaccine distribution in developing and remote regions.
#biotech #biotechnology #science
December 16, 2025 at 5:22 PM
vanjohn10.bsky.social
Trinity Capital’s Rob Lake looks at private capital’s ability to stretch runway to achieve milestones while minimizing dilution
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation
December 16, 2025 at 5:00 PM
vanjohn10.bsky.social
Lexaria Bioscience $3.5mm raise
*2.66mm shares
*$1.315/sh
*2.66mm warrants @ $1.19
*Close expected today
$LEXX
finance.yahoo.com/news/lexaria...
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
KELOWNA, BC / ACCESS Newswire / December 15, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it h...
finance.yahoo.com
December 16, 2025 at 2:52 PM
vanjohn10.bsky.social
TuHURA releases Kintara's REM001 CVR
*Releases 1.5mm $HURA shares to former Kintara shareholders
*10 patients
*Meets safety endpoint & signs of clinical efficacy
*With primary focus on IFx2.0, anti-VISTA & DOR inhibitor, next steps for REM001 unclear
finance.yahoo.com/news/tuhura-...
TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone
TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that...
finance.yahoo.com
December 16, 2025 at 2:38 PM
vanjohn10.bsky.social
Dyadic partners with Opes Diagnostics to commercialize $DYAI's recombinant human transferrin, bovine transferrin, human FGF, and bovine FGF products for use in serum-free cell culture media applications in life science, food & nutrition
*EU, Israel & Asia
finance.yahoo.com/news/dyadic-...
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
JUPITER, Fla., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes ...
finance.yahoo.com
December 15, 2025 at 1:30 PM
vanjohn10.bsky.social
Radiopharm Theranostics reports 92% concordance between RAD101 & MRI as assessed by PET imaging of brain metastases
*Significant & selective tumor uptake
*Call @ 6 pm ET tonight
$RADX
finance.yahoo.com/news/radioph...
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
92% of evaluable patients at interim analysis treated with RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent b...
finance.yahoo.com
December 15, 2025 at 1:25 PM
vanjohn10.bsky.social
Dr. Ann Childress, principal investigator on Cingulate's CTx-1301 trials shares other data reported from the study. Notably, & in contrast to the pediatric study, the adult study was mostly female.
$CING
youtu.be/Rl_co75JDB8
CTx 1301 Adult Data
YouTube video by Unboxing Biotech
youtu.be
December 14, 2025 at 5:15 PM
vanjohn10.bsky.social
#CEO David Dodd looks at the possible futures for GeoVax and the company’s focus during a surge in M&A activity.
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch #Oncology #InnovativeMedicine #Biotech #TargetedTherapy
December 13, 2025 at 7:37 PM
vanjohn10.bsky.social
Trinity Capital’s Rob Lake looks at private capital’s ability to stretch runway to achieve milestones while minimizing dilution
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation
December 13, 2025 at 7:34 PM
vanjohn10.bsky.social
GeoVax' #CEO David A. Dodd looks at the Modified Vaccinia Ankara (MVA) platform & how $GOVX is adapting it to be used in developing and developed regions alike.
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch #Oncology
December 12, 2025 at 8:54 PM